Tg Therapeutics TGTX
NASDAQ TGTX
$54.44 -1.33 (-2.39%)
As of: Oct 1, 2026 · 12:06 PM EDT

Tg Therapeutics (TGTX) EV to CFO (2024 - 2026)

Updated

Tg Therapeutics' (TGTX) EV to CFO was 436.22 for Q2 2026.

Analysis

Tg Therapeutics (TGTX) EV to CFO (2024 - 2026) Analysis & Trends

  • The Q2 2026 figure ranks as the lowest quarterly EV to CFO since Q2 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Tg Therapeutics 8.54 Bn 7.93 Bn 199.14 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 436.22
Jun 30, 2024 37.41
Mar 31, 2024 105.57
API Access

Tg Therapeutics EV to CFO API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=TGTX&period=max&api_key=YOUR_API_KEY